ESC 2026
28 - 31 August 2026
Adiposity-related HFpEF: Building on GLP-1 and advancing beyond
Sunday, 30 August 2026
12:30 - 12:32
(CEST)
Opening & welcome
Carolyn Lam
12:32 - 12:45
(CEST)
Adiposity in HFpEF: A key driver of disease pathophysiology
Carolyn Lam
12:45 - 13:00
(CEST)
Incretin therapies in adiposity-related HFpEF: From evidence to guidelines
Mark Petrie
13:00 - 13:15
(CEST)
Exploring next-generation incretin therapy: Insights and opportunities
Katharina Marx-Schütt
13:15 - 13:30
(CEST)
Q&A
Carolyn Lam, Mark Petrie, Katharina Marx-Schütt
Keywords